Why the study?
Does pimobendan improve clinical scores and survival compared to benazepril in dogs with acquired atrioventricular valvular disease?
Population
76 dogs with clinical acquired atrioventricular valvular disease
Comparison
Pimobendan vs Benazepril hydrochloride
Design
RCT, randomized
Follow-up
56 days and long-term
Authors
Loading...
Supports preferential pimobendan use over benazepril; extends RCT evidence for survival benefit in canine AV valvular disease.
Does pimobendan improve clinical scores and survival compared to benazepril in dogs with acquired atrioventricular valvular disease?
Pimobendan significantly improves clinical scores and prolongs survival compared to benazepril in dogs with acquired atrioventricular valvular disease.
Lombard et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: